Pfizer Inc. (PFE) reported fourth-quarter net income attributable to the company of $767 million or $0.10 per share, compared to net income of $266 million or $0.04 per share in the same quarter last year.
On an adjusted basis, net income was $3.83 billion or $0.49 per share, compared to net income of $4.39 billion or $0.65 per share in the year ago quarter. Analysts polled by Thomson Reuters expected the company to report earnings of $0.50 per share for the quarter. Analysts' estimates typically exclude special items.
Revenues for the quarter were $16.54 billion, up from $12.35 billion in the comparable quarter last year. Thirteen analysts had consensus revenue estimate of $15.88 billion for the quarter.
For fiscal 2010, the company expects reported earnings per share to be in the range of $0.95 to $1.10, and adjusted earnings per share to be in the range of $2.10 to $2.20. Reported revenues are expected to be between $67.0 billion and $69.0 billion. Analysts expect the company to report earnings of $2.27 per share on revenues of $67.47 billion for fiscal 2010. Analysts' estimates typically exclude special items.
For 2012, at current exchange rates, Pfizer is targeting reported revenue between $66.0 billion to $68.5 billion, reported EPS between $1.58 and $1.73 and adjusted EPS between $2.25 and $2.35.
For comments and feedback: editorial@rttnews.com